Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. DNTH
DNTH logo

DNTH News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

DNTH News

Dianthus Therapeutics Prices Upsized $625 Million Public Offering

1d agoseekingalpha

Dianthus Therapeutics Prices $625 Million Upsized Public Offering

1d agoNASDAQ.COM

Wall Street Analysts Adjust Ratings

2d agoBenzinga

Wall Street Analysts Adjust Ratings

2d agoBenzinga

Dianthus Therapeutics Launches $400 Million Public Offering

3d agoseekingalpha

Liquidia and Dianthus See Active Options Trading

3d agoNASDAQ.COM

Dianthus Therapeutics Early Decision Boosts Stock Surge

3d agostocktwits

Relmada Therapeutics Shares Surge 40.8% on Promising Trial Data

3d agoBenzinga

DNTH Events

03/11 06:10
Deal Size Increased to $625M in Common Stock
The deal size was increased to $625M in common stock from $400M in common stock. Jefferies, Evercore ISI, Stifel, Guggenheim and William Blair acted as joint book running managers for the offering.

DNTH Monitor News

Dianthus Therapeutics Surges After Positive Trial Results

Mar 10 2026

Dianthus Reports Positive CAPTIVATE Trial Results Amid Earnings Miss

Mar 09 2026

DNTH Earnings Analysis

No Data

No Data

People Also Watch